Latest news
FDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 16:08:00 GMTModerna’s FDA Adcomm, IPO Mania, Biopharma Layoffs, More Beautiful Anticipazioni (6lY4UJTZKu) - MshaleMshale · Tue, 04 Aug 2026 16:58:39 GMTFDA AdComm Votes Against Recommending Deramiocel Approval, Tazbentetol Shows Durable Cognitive Benefit in AD, Salanersen's FDA Breakthrough Designation Meaning - NeurologyLiveNeurologyLive · Sat, 01 Aug 2026 23:14:57 GMTThis Week at FDA: ‘Simple reform’ reorg, adcomm updates, and more - RAPSRAPS · Fri, 31 Jul 2026 21:20:00 GMTAdcomm backs Replimune melanoma drug, despite data concern - pharmaphorumpharmaphorum · Fri, 31 Jul 2026 07:00:00 GMTCapricor CEO won’t rule out legal action against FDA after negative adcomm - BioSpaceBioSpace · Fri, 31 Jul 2026 07:00:00 GMTReplimune’s twice-rejected melanoma drug prevails in FDA adcomm - Fierce BiotechFierce Biotech · Thu, 30 Jul 2026 07:00:00 GMTReplimune overcomes ‘messy data’ to secure positive adcomm vote for melanoma therapy - BioSpaceBioSpace · Thu, 30 Jul 2026 07:00:00 GMT